The early weeks of January are a wonderful time to reshuffle your stock portfolio and buy great stocks with big long-term ...
With rapid advances in artificial intelligence (AI), the biotech industry may penetrate deeper into many previously ...
As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability ...
Explore the best ETFs to buy in 2025. Discover top picks across a variety of sectors with insights to help you diversify and ...
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today ... While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Needham analyst Ami Fadia maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) today and set a price target of $133.00.Don't ...
Finbold tapped into Wall Street analysts’ projections to spotlight stocks with the most "Buy" ratings, offering a glimpse ...
ARKF ETF has sold $15 million worth of shares of Palantir stock, may have caused a bit of a sell-off. See why I maintain a ...
SoundHound is making rapid strides in the voice AI and conversational intelligence space. Agentic automation looks likely to be a major opportunity for robotic specialist UiPath. The U.S. stock market ...